- Home
- ATYR vs WGRX Comparison
ATYR vs WGRX Comparison
Compare ATYR & WGRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATYR
- WGRX
- Stock Information
- Founded
- ATYR 2005
- WGRX 2022
- Country
- ATYR United States
- WGRX United States
- Employees
- ATYR N/A
- WGRX N/A
- Industry
- ATYR Biotechnology: Biological Products (No Diagnostic Substances)
- WGRX Other Pharmaceuticals
- Sector
- ATYR Health Care
- WGRX Health Care
- Exchange
- ATYR Nasdaq
- WGRX Nasdaq
- Market Cap
- ATYR 105.8M
- WGRX 111.0M
- IPO Year
- ATYR 2015
- WGRX 2025
- Fundamental
- Price
- ATYR $0.93
- WGRX $0.70
- Analyst Decision
- ATYR Buy
- WGRX
- Analyst Count
- ATYR 6
- WGRX 0
- Target Price
- ATYR $8.88
- WGRX N/A
- AVG Volume (30 Days)
- ATYR 23.5M
- WGRX 1.2M
- Earning Date
- ATYR 11-06-2025
- WGRX 11-11-2025
- Dividend Yield
- ATYR N/A
- WGRX N/A
- EPS Growth
- ATYR N/A
- WGRX N/A
- EPS
- ATYR N/A
- WGRX N/A
- Revenue
- ATYR N/A
- WGRX $36,738,599.00
- Revenue This Year
- ATYR $420.85
- WGRX N/A
- Revenue Next Year
- ATYR $1,919.44
- WGRX N/A
- P/E Ratio
- ATYR N/A
- WGRX N/A
- Revenue Growth
- ATYR N/A
- WGRX 82384.51
- 52 Week Low
- ATYR $0.68
- WGRX $0.62
- 52 Week High
- ATYR $7.29
- WGRX $7.04
- Technical
- Relative Strength Index (RSI)
- ATYR 27.94
- WGRX 31.93
- Support Level
- ATYR $0.68
- WGRX $0.64
- Resistance Level
- ATYR $0.86
- WGRX $1.03
- Average True Range (ATR)
- ATYR 0.08
- WGRX 0.12
- MACD
- ATYR 0.13
- WGRX -0.04
- Stochastic Oscillator
- ATYR 69.00
- WGRX 7.74
About ATYR aTyr Pharma Inc. Common Stock
aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.
About WGRX Wellgistics Health Inc. Common Stock
Wellgistics Health Inc is a healthcare technology and pharmaceutical logistics company. It simplifies the logistics of prescription fulfillment from the manufacturer and provider to the patient. It is focused on improving the lives of patients while delivering unique solutions for pharmacies, providers, pharmaceutical manufacturers, and payors.